As filed with the U.S. Securities and Exchange Commission on January 30, 2026. Registration No. 333-[•] UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________ FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 _____________________________________ Averin Capital Acquisition Corp. (Exact name of registrant as specified in its charter) _____________________________________ Cayman Islands 6770 98-1891461 (State or other jurisdiction of incorp ...

On January 27, Sherry Paul, a senior portfolio manager at Morgan Stanley, appeared on CNBC’s ‘Closing Bell’ to discuss whether more volatility is ahead, following a volatile week in the market. Paul clarified that volatility is a standard part of investing that signifies something emergent rather than something inherently bad. She believes that the market is moving away from the ‘Magnificent Seven’ and toward what she calls ‘magnificent thematics.’ These themes include the new world order, AI automation, in ...

Core Viewpoint - The market is experiencing renewed volatility post-Davos, with a shift in sentiment from bullish to cautious, emphasizing the urgency of reimagining supply chains and advancing technology in the U.S. [3][4] Group 1: Market Sentiment and Trends - The transition from a "pre-Davos" bullish market to a "post-Davos" environment indicates increased volatility, with a notable "sell America" trend and a weaker dollar [1][3]. - The phrase "new world order" has replaced "deglobalization," suggesting a more urgent need for changes in supply chains and technology [3][4]. Group 2: Investment Strategies - Investors are encouraged to focus on thematic areas such as AI, automation, and innovation rather than solely on traditional mega-cap stocks [5][6]. - The importance of equal weighting in investment portfolios is highlighted, as traditional market cap-weighted strategies may overlook emerging value in various sectors [6][7]. Group 3: Technology Sector Insights - Every company is now viewed as a tech company, necessitating an understanding of AI's application in business models to avoid potential extinction events [7][10]. - The software sector is currently underperforming, with many stocks showing little movement, indicating vulnerability in the context of advanced AI [8][9].

SBC Medical Group Holdings Conference Summary Company Overview - SBC Medical Group Holdings is the largest aesthetic medical group in Japan, providing comprehensive management support services to franchise clinics and generating income through franchise fees [2][3] - The company has expanded its franchise clinics to 258 locations, serving approximately 6.5 million customers annually [3] Industry Insights - The aesthetic medicine market in Japan remains competitive but is showing signs of improvement compared to the previous year [22] - The average revenue per customer visit had temporarily declined but is now recovering due to strategic initiatives [4][22] Financial Performance - Sales declined in Q2 2025 due to business restructuring and franchise fee revisions, but signs of recovery are evident [4] - The company maintains a robust financial foundation with sufficient cash and deposits, and aims to sustain a high EBITDA margin [4][5] Global Expansion Strategy - SBC is focused on expanding its operations outside Japan, particularly in the U.S. and Southeast Asia, while also deepening its presence in the Japanese market [6][23] - The partnership with OrangeTwist, a U.S.-based med spa, is a key component of this strategy, allowing SBC to leverage OrangeTwist's platform and customer experience [9][10] Partnership with OrangeTwist - OrangeTwist operates 24 clinics across several U.S. states and is co-founded by industry veterans, providing a strong platform for collaboration [9][10] - The partnership aims to introduce differentiated experiences in both the U.S. and Japan, potentially including product distribution and joint clinics [12][14] M&A Strategy - SBC plans to pursue M&A opportunities primarily in Japan, leveraging its scale and operational efficiencies [19][21] - The company is also exploring potential acquisitions in Southeast Asia and the U.S. as part of its global strategy [20][21] Market Dynamics - The aesthetic market in the U.S. is experiencing consolidation, presenting opportunities for SBC to enter and grow [11] - SBC's flexible platform allows for adjustments in clinic offerings to meet diverse customer needs, including potential expansion into general medical areas like dentistry and orthopedics [24] Customer Experience and Treatment Differences - SBC emphasizes the importance of customer experience, noting that treatments popular in Japan may not translate directly to the U.S. market [32][33] - The company aims to learn from OrangeTwist's customer engagement strategies to enhance its offerings in the U.S. [34] Future Outlook - SBC's long-term goal is to become the preferred medical group globally by 2050, with a cautious and disciplined approach to expansion [13][18] - The company plans to gradually increase investments as it gains market knowledge and identifies successful strategies [17][18] Conclusion - SBC Medical Group Holdings is strategically positioned for growth through its strong domestic presence, international partnerships, and a focus on customer experience in the evolving aesthetic medicine market [35]

Financial Data and Key Metrics Changes - The company pre-announced preliminary fourth quarter results with a slight downtick in revenue guidance, attributed to weaker performance in November, but December rebounded strongly, leading to a positive outlook for 2026 [3][4] - Guest spend reached the highest level ever, with metrics indicating strong performance during the holiday season [12] Business Line Data and Key Metrics Changes - The company is focusing on expanding its acupuncture and med spa services, which currently account for about 8% of total revenue and are growing at 10% annually [9] - The reorganization included exiting the Asia land-based operation, which will not impact EBITDA but will affect revenue numbers [6][7] Market Data and Key Metrics Changes - The company noted a strong consumer appetite for wellness services, particularly in the maritime segment, indicating a trend towards higher guest spending [9][11] - Pre-booking rates are currently around 22%, with a goal to increase this to 30%, as pre-booked guests tend to spend 35% more than those who book on board [16][21] Company Strategy and Development Direction - The company is implementing machine learning and AI initiatives to enhance revenue and efficiency, with plans to roll out these technologies across more vessels [22][23] - The focus is on maintaining collaborative relationships with cruise line partners to grow the overall business rather than competing for smaller slices of revenue [40][41] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in maintaining pricing power across different macro environments, citing strong demand for services [13][14] - The company is optimistic about the future, particularly in the wellness and longevity sectors, and is exploring new service offerings [10][32] Other Important Information - The company returned $92.9 million to shareholders in 2025 through share repurchases and dividends while also investing in debt pay down [36] - Staff retention has improved significantly, with a current retention rate of 76%, which enhances productivity and reduces training costs [30] Q&A Session Summary Question: Can you provide insights on the pre-announcement and fourth quarter results? - Management noted a slight revenue guide downtick due to November's performance but highlighted a strong December, leading to a positive outlook for 2026 [3][4] Question: What are the implications of closing the Asia land-based facility? - The exit will not impact EBITDA but will affect revenue, as the operation was not profitable [6][7] Question: How is the company addressing the growth in guest spending? - The company has reworked service offerings to encourage longer and higher-priced treatments, which has successfully driven guest spending [11][12] Question: What is the strategy for improving pre-booking rates? - Management aims to enhance pre-booking capabilities and increase visibility on mobile platforms to boost rates from 22% to 30% [16][21] Question: How does the company view its relationships with cruise line partners? - The focus has shifted to collaborative growth with cruise lines, emphasizing the importance of enhancing the overall guest experience [40][41]

Core Insights - EUDA Health Holdings Limited is set to launch EUDA Helixé 2.0 in January 2026, representing a significant upgrade in its premium vitality and longevity supplement line [1][6] Product Enhancements - The new formulation includes a 20% increase in New Zealand sourced deer placenta powder, raising the dosage from 100 mg to 120 mg, enhancing its potency [2] - L-glutathione has been replaced with D-alpha-tocopherol (Vitamin E, 1.4 mg equivalent) to improve antioxidant stability and support skin health [2] - Advanced encapsulation technology has been implemented to enhance stability, absorption efficiency, and shelf life, utilizing a nano-based delivery system for smaller capsule sizes [3][8] Packaging and Design - A new proprietary bottle design has been introduced to reflect the premium positioning of EUDA Helixé, enhancing product protection and brand identity [4] Market Expansion - EUDA Helixé 2.0 has received New Zealand Halal certification, facilitating broader international distribution and entry into Muslim markets across Southeast Asia and the Middle East [5] Strategic Positioning - The launch of EUDA Helixé 2.0 underscores the company's commitment to innovation and global wellness solutions, positioning it as a core offering within EUDA's health and longevity ecosystem [6][7] - The company aims to address the healthcare needs of over 1.8 billion people in Asia, focusing on the growing longevity sector as populations age [9]

SINGAPORE, Dec. 23, 2025 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) “EUDA” or “the Company”, a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced a significant acceleration of its longevity and regenerative medicine strategy with the launch of a comprehensive stem cell therapy platform and establishment of its first clinic in Shenzhen, China. This strategic advancement builds on the Company’s earlier acquisition of distrib ...

Core Viewpoint - Celularity Inc. has successfully closed a financing transaction, enhancing its financial position and supporting its strategic initiatives in regenerative and cellular medicine [1][4]. Financing Details - Celularity received $10.00 million in gross proceeds from the financing, with the potential for an additional $2.0 million based on specific conditions [2]. - The financing structure includes a senior secured term loan of $7.0 million and secured convertible notes with commitments of up to $5.0 million, convertible at a price of $1.66 per share [3]. - The secured convertible notes are backed by a first-priority lien on proceeds from a qualified financing, and Celularity issued warrants for 3,707,657 shares of Class A Common Stock with an exercise price of $2.00 per share [3]. Strategic Focus - The company aims to leverage its placental-derived platform to address significant unmet medical needs related to healthy aging and performance optimization [4]. - Celularity plans to articulate its corporate strategy in the upcoming year, aligning its scientific capabilities with long-term opportunities in longevity and age-related diseases [5]. Company Overview - Celularity Inc. specializes in developing, manufacturing, and commercializing advanced biomaterial products and cell therapies derived from postpartum placenta, targeting fundamental aging mechanisms [7].

I have a confession to make. When I pick up a newspaper, the first thing I do is flip straight to the obituaries. That's right, the obits.It's not because I'm morbid, and it's not because I've been a gerontologist since the field was in its infancy. It's because obituaries are the true highlight reels of our lives. In just a few paragraphs, you see what truly mattered.The passions, the quirks, the loves lost and gained, the impact, the risks taken or not. They're a masterclass in what it takes to live, not ...

Salus Populi Suprema Lex Exto. Il welfare dei cittadini è la legge suprema. Questa è l'iscrizione che trovate in giro per gli edifici pubblici di tutto il mondo ed è forse la regola principale.La nostra salute è la legge suprema. Per la prima volta su questo pianeta ci sono sei generazioni che vivono insieme. Cinque di queste votano insieme, vanno a bere il caffè insieme, si trovano nei barsi nel 2050 ci saranno 2 miliardi di persone over 60 su questo pianeta.Non era mai successo prima. E questo è un argome ...